Major depressive disorder (MDD) is characterized by a lowered mood and loss of interest, contributing not only to ...

New research suggests that microdosing a popular psychedelic may provide relief for people struggling with major depressive ...

Major depressive disorder (MDD) is characterized by a lowered mood and loss of interest, contributing not only to ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...

But when the researchers analyzed the data, they found that fluoxetine appeared not to provide meaningful benefits for ...

The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults, Johnson & Johnson announced. Lumateperone was previously ...

The FDA has granted 510(k) clearance and a label expansion for a transcranial magnetic stimulation device to treat patients ...

A growing body of research suggests that vitamin D may play a subtler role in mood than previously assumed, becoming most ...

Despite the advice of two of the most successful pop anthems of the last two decades, when it comes to depression, no one can ...

A large cohort study found that swapping TV-watching for physical activity can meaningfully lower the risk of depression, particularly in middle-aged adults. A study published in European Psychiatry r ...

The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...